Product Information
MEFLOQUINE HCL 250 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $4.1402 per EA under NDC 62135097325. Its NADAC has been published 72 times since Apr 9, 2025.
FDA first approved this application on Feb 20, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Chartwell RX LLCNDC
62135097325
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
MEFLOQUINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076175FDA Approved
2/20/2002
TE Code
AB
On Market Since
2/20/2022
Pharmacological Classes
Price Statistics
The NADAC for MEFLOQUINE HCL 250 MG TABLET has been published 72 times since Apr 9, 2025, and over the history we have for it it has risen 31.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.1402 per EA |
|---|---|
| All-time high | $5.0310 (Oct 15, 2025) |
| All-time low | $3.1377 (Apr 9, 2025) |
| 52-week high | $5.0310 |
| 52-week low | $4.0689 |
| Median price | $4.2582 |
| Average price | $4.1560 |
| Largest weekly change | +52.2% (Aug 20, 2025) |
| Weeks tracked | 72 |
| Tracking since | Apr 9, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MEFLOQUINE HCL 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MEFLOQUINE HCL 250 MG TABLET, manufactured by Chartwell RX LLC, is $4.1402 per EA (NDC 62135097325), effective Aug 19, 2026.
How has the price of MEFLOQUINE HCL 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for MEFLOQUINE HCL 250 MG TABLET has risen 31.9%. It has been tracked across 72 weekly CMS publications since Apr 9, 2025.
What are the highest and lowest recorded NADAC prices for MEFLOQUINE HCL 250 MG TABLET?
Since Apr 9, 2025, the NADAC for MEFLOQUINE HCL 250 MG TABLET has ranged from a low of $3.1377 (Apr 9, 2025) to a high of $5.0310 (Oct 15, 2025), with a median of $4.2582 per EA.
Are there cheaper alternatives to MEFLOQUINE HCL 250 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as MEFLOQUINE HCL 250 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures MEFLOQUINE HCL 250 MG TABLET?
MEFLOQUINE HCL 250 MG TABLET (NDC 62135097325) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.